Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
China · Delayed Price · Currency is CNY 114.85
-5.39 (-4.48%)
Apr 21, 2026, 3:00 PM CST
Beijing Hotgen Biotech Market Cap
Beijing Hotgen Biotech has a market cap or net worth of 10.68 billion as of April 21, 2026. Its market cap has increased by 30.56% in one year.
Market Cap
10.68B
Enterprise Value
9.64B
Revenue
407.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
114.85
Market Cap Chart
Since September 30, 2019, Beijing Hotgen Biotech's market cap has increased from 4.41B to 10.68B, an increase of 142.26%. That is a compound annual growth rate of 14.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 10.68B | -25.78% |
| Dec 31, 2025 | 14.39B | 159.78% |
| Dec 31, 2024 | 5.54B | 50.94% |
| Dec 29, 2023 | 3.67B | -34.53% |
| Dec 30, 2022 | 5.61B | -22.40% |
| Dec 31, 2021 | 7.22B | 197.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pacific Shuanglin Bio-pharmacy | 12.27B |
| Hualan Biological Vaccine | 11.85B |
| Chengdu Olymvax Biopharmaceuticals | 11.81B |
| Chengdu Easton Biopharmaceuticals | 11.66B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 11.51B |
| Chongqing Genrix Biopharmaceutical | 11.41B |
| Aurisco Pharmaceutical | 11.19B |
| HitGen | 10.75B |